These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 499338)

  • 41. A study on the antagonism of the intestinal inhibitory effects of morphine and clonidine by yohimbine in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):715-9. PubMed ID: 3027469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymphoma, analgesia and excitability after morphine administration in mice.
    Eldridge D; Vredevoe DL; Levy L
    Proc West Pharmacol Soc; 1984; 27():443-6. PubMed ID: 6494183
    [No Abstract]   [Full Text] [Related]  

  • 43. The development of cross tolerance between ethanol and morphine.
    Fidecka S; Tamborska E; Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1986; 38(3):277-84. PubMed ID: 3774626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unilateral analgesia produced by intraventricular morphine.
    Cohen SR; Abbott FV; Melzack R
    Brain Res; 1984 Jun; 303(2):277-87. PubMed ID: 6744024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological investigations of a yohimbine-impulsivity interaction in rats.
    Mahoney MK; Barnes JH; Wiercigroch D; Olmstead MC
    Behav Pharmacol; 2016 Oct; 27(7):585-95. PubMed ID: 27509312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of dopaminergic modifiers on morphine-induced analgesia and respiratory depression.
    McGilliard KL; Takemori AE
    Eur J Pharmacol; 1979 Feb; 54(1-2):61-8. PubMed ID: 33817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of group-A10 dopamine neurons of the ventral tegmental area in analgesia evoked by electrocutaneous pain stimulation and morphine].
    Bragin EO; Batueva NN; Vasilenko GF
    Patol Fiziol Eksp Ter; 1990; (3):11-3. PubMed ID: 2399031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Site dependent analgesia after microinjection of morphine or lanthanum in rat brain.
    Harris RA; Iwamoto ET; Loh HH; Way EL
    Proc West Pharmacol Soc; 1975; 18():275-8. PubMed ID: 1178680
    [No Abstract]   [Full Text] [Related]  

  • 49. Yohimbine does not affect opioid receptor activation but prevents adenylate cyclase regulation by morphine in NG108-15 cells.
    Polanco MJ; López-Giménez JF; González-Martín C; Alguacil LF
    Life Sci; 2011 Aug; 89(9-10):327-30. PubMed ID: 21763325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The alpha2-adrenoceptor antagonist yohimbine reduces glial fibrillary acidic protein upregulation induced by chronic morphine administration.
    Garrido E; Pérez-García C; Alguacil LF; Díez-Fernández C
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):141-4. PubMed ID: 15936527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Met-enkephalin attenuates morphine tolerance in rats.
    Gráf L; Miglécz E; Bajusz S; Székely JI
    Eur J Pharmacol; 1979 Oct; 58(3):345-6. PubMed ID: 510369
    [No Abstract]   [Full Text] [Related]  

  • 52. Unsuccessful attempts to transfer morphine tolerance and passive avoidance by brain extracts.
    Goldstein A; Sheehan P; Goldstein J
    Nature; 1971 Sep; 233(5315):126-9. PubMed ID: 12058754
    [No Abstract]   [Full Text] [Related]  

  • 53. Factors affecting restraint stress-induced potentiation of morphine analgesia.
    Calcagnetti DJ; Holtzman SG
    Brain Res; 1990 Dec; 537(1-2):157-62. PubMed ID: 2085771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal and adult gonadal hormone manipulations enhance morphine analgesia elicited from the ventrolateral periaqueductal gray in female rats.
    Cataldo G; Bernal SY; Rozengurtel S; Medina K; Bodnar RJ
    Int J Neurosci; 2010 Apr; 120(4):265-72. PubMed ID: 20374074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different mechanisms mediating tail-flick inhibition induced by beta-endorphin, DAMGO and morphine from ROb and GiA in anesthetized rats.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):530-8. PubMed ID: 2020008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neural activation profile elicited by cues associated with the anxiogenic drug yohimbine differs from that observed for reward-paired cues.
    Schroeder BE; Schiltz CA; Kelley AE
    Neuropsychopharmacology; 2003 Jan; 28(1):14-21. PubMed ID: 12496936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histaminergic mechanisms in clonidine induced analgesia in rat tail-flick test.
    Arrigo-Reina R; Chiechio S
    Inflamm Res; 1995 Jan; 44(1):21-3. PubMed ID: 7664025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No evidence for a protracted change in endogenous opioid activity following chronic opiate treatment in mice: parallel recovery of cross tolerance to stress and morphine antinociception.
    Christie MJ; Chesher GB; Bird KD
    Psychopharmacology (Berl); 1984; 82(4):379-81. PubMed ID: 6427832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Yohimbine both increases and decreases nociceptive thresholds in rats: evaluation of the dose-response relationship.
    Paalzow GH; Paalzow LK
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr; 322(3):193-7. PubMed ID: 6306484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoaminergic mechanisms in stress-induced analgesia.
    Jensen TS; Smith DF
    J Neural Transm; 1982; 53(4):247-55. PubMed ID: 6286868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.